Antiviral activity of amantadine: a review of laboratory and clinical data.
D000547:Amantadine / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents; D046508:Culture Techniques; D004352:Drug Resistance, Microbial; D006388:Hemagglutinins / Q000096:biosynthesis; D006801:Humans; D007252:Influenza Vaccines / Q000494:pharmacology; D007372:Interferons / Q000494:pharmacology; D009975:Orthomyxoviridae / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology; D012008:Recurrence; D012254:Ribavirin / Q000494:pharmacology; D014611:Vaccination / Q000191:economics; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D006388:Hemagglutinins; D007252:Influenza Vaccines; D010455:Peptides; D012254:Ribavirin; D007372:Interferons; D000547:Amantadine